Chiron Real Estate Statistics
Total Valuation
XRN has a market cap or net worth of $496.68 million. The enterprise value is $1.16 billion.
| Market Cap | 496.68M |
| Enterprise Value | 1.16B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | Jun 22, 2026 |
Share Statistics
XRN has 13.68 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 13.23M |
| Shares Outstanding | 13.68M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 65.21% |
| Float | 12.30M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.28 |
| Forward PS | 3.06 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.65 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.64 |
| EV / EBITDA | 12.67 |
| EV / EBIT | 31.66 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 1.30.
| Current Ratio | 0.99 |
| Quick Ratio | 0.78 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | 7.03 |
| Debt / FCF | n/a |
| Interest Coverage | 1.15 |
Financial Efficiency
Return on equity (ROE) is -1.69% and return on invested capital (ROIC) is 1.89%.
| Return on Equity (ROE) | -1.69% |
| Return on Assets (ROA) | 1.82% |
| Return on Invested Capital (ROIC) | 1.89% |
| Return on Capital Employed (ROCE) | 3.02% |
| Weighted Average Cost of Capital (WACC) | 6.59% |
| Revenue Per Employee | $5.05M |
| Profits Per Employee | -$498,967 |
| Employee Count | 30 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.45% in the last 52 weeks. The beta is 1.14, so XRN's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +15.45% |
| 50-Day Moving Average | 35.42 |
| 200-Day Moving Average | 34.57 |
| Relative Strength Index (RSI) | 52.85 |
| Average Volume (20 Days) | 167,462 |
Short Selling Information
The latest short interest is 630,185, so 4.61% of the outstanding shares have been sold short.
| Short Interest | 630,185 |
| Short Previous Month | 525,582 |
| Short % of Shares Out | 4.61% |
| Short % of Float | 5.12% |
| Short Ratio (days to cover) | 2.84 |
Income Statement
In the last 12 months, XRN had revenue of $151.53 million and -$14.97 million in losses. Loss per share was -$1.12.
| Revenue | 151.53M |
| Gross Profit | 151.53M |
| Operating Income | 36.58M |
| Pretax Income | -8.97M |
| Net Income | -14.97M |
| EBITDA | 91.40M |
| EBIT | 36.58M |
| Loss Per Share | -$1.12 |
Balance Sheet
The company has $15.40 million in cash and $676.75 million in debt, with a net cash position of -$661.35 million or -$48.35 per share.
| Cash & Cash Equivalents | 15.40M |
| Total Debt | 676.75M |
| Net Cash | -661.35M |
| Net Cash Per Share | -$48.35 |
| Equity (Book Value) | 520.65M |
| Book Value Per Share | 28.42 |
| Working Capital | -407,000 |
Cash Flow
| Operating Cash Flow | 74.69M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 44.81M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 24.14% and -5.06%.
| Gross Margin | 100.00% |
| Operating Margin | 24.14% |
| Pretax Margin | -5.92% |
| Profit Margin | -5.06% |
| EBITDA Margin | 60.32% |
| EBIT Margin | 24.14% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.92, which amounts to a dividend yield of 5.18%.
| Dividend Per Share | $1.92 |
| Dividend Yield | 5.18% |
| Dividend Growth (YoY) | -38.21% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | 4.59% |
| Earnings Yield | -3.01% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for XRN is $35.91, which is -1.10% lower than the current price. The consensus rating is "Buy".
| Price Target | $35.91 |
| Price Target Difference | -1.10% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 4.95% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 22, 2025. It was a reverse split with a ratio of 1:5.
| Last Split Date | Sep 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |